OptoDArG

CAS No. 2230617-93-1

OptoDArG( ——— )

Catalog No. M39439 CAS No. 2230617-93-1

OptoDArG is a photoswitchable probe that has the activity to recognize lipid-gated pores by controlling TRPC3 channels and can be used as a tool to study the lipid sensing mechanism of TRPC channels.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    OptoDArG
  • Note
    Research use only, not for human use.
  • Brief Description
    OptoDArG is a photoswitchable probe that has the activity to recognize lipid-gated pores by controlling TRPC3 channels and can be used as a tool to study the lipid sensing mechanism of TRPC channels.
  • Description
    OptoDArG is a diacylglycerol (DAG) photoswitch, which enables efficient control of TRPC3 by light.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    2230617-93-1
  • Formula Weight
    704.9
  • Molecular Formula
    C43H52N4O5
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. An optically controlled probe identifies lipid-gating fenestrations within the TRPC3 channel
molnova catalog
related products
  • HO-PEG16-OH

    HO-PEG16-OH is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

  • BIBF0775

    BIBF0775 is a selective TGFβ type I receptor (Alk5) inhibitor (IC50: 34 nM).

  • Antiproliferative ag...

    Antiproliferative agent-16 (Antiproliferative agent-16) is an indolyl hydrazide-hydrazone compound with anticancer activity. Antiproliferative agent-16 exhibits specificity toward breast cancer cells (IC50 of 6.94 μM for MCF-7 cells).